Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06394739 · ClinicalTrials.gov registry record
RevCore for In Stent Thrombosis
A clinical trial of In-stent Thrombosis, sponsored by Inari Medical.
- Recruiting
- Registry status
- 100
- Enrollment target
- 15
- Study locations
NCT06394739 is a study of In-stent Thrombosis that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 100 participants. The trial reports 15 study locations across 12 states.
The verdict
NCT06394739, a study of In-stent Thrombosis, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Conditions Studied
Interventions
- DEVICE Thrombectomy
Study Locations (15)
Pennsylvania
- University of Pennsylvania - Philadelphia
- Thomas Jefferson University - Philadelphia
- Allegheny Health Network Research Institute - Pittsburgh
Ohio
- UH Cleveland Medical Center - Cleveland
- Ohio State University - Columbus
Connecticut
- Yale University - New Haven
District of Columbia
- Medstar Health Research Institute - Washington D.C.
Maryland
- University of Maryland - Baltimore
New York
- New York University- Langone - New York
North Carolina
- Mission Health - Asheville
South Carolina
- Spartanburg Medical Center - Spartanburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06394739
The ClinicalTrials.gov registry entry for NCT06394739 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with In-stent Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Thrombectomy is the first listed.
NCT06394739 reports 15 study locations spanning 12 distinct geographic areas - top geographies include Pennsylvania, Ohio, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06394739 about?
NCT06394739 is a clinical study titled "RevCore for In Stent Thrombosis". The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
What is the current status of trial NCT06394739?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-09-09. Estimated completion is 2028-04.
What conditions does trial NCT06394739 study?
This clinical trial studies the following conditions: In-stent Thrombosis.
What interventions are being tested in trial NCT06394739?
The interventions under investigation include: Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT06394739?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06394739 being conducted?
This trial has 15 study locations across Connecticut, District of Columbia, Maryland, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.